Physician profile
Michael C Brown
NPI 1164548244
$402.40
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.92 · 2020: $106 · 2021: $214 · 2022: $24.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $109.51 | 2021-2022 | |
| Pfizer INC. | $108.67 | 2021 | |
| Sunovion Pharmaceuticals INC. | $62.20 | 2020-2021 | |
| Allergan, INC. | $35.34 | 2020 | |
| Janssen Pharmaceuticals, INC | $28.76 | 2020 | |
| Antares Pharma, INC. | $25.94 | 2019 | |
| Kaleo, INC. | $18.11 | 2019 | |
| Orexo US, INC. | $13.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.